Production of nerve growth factor (ngf) and of muteins thereof
AssigneeChiesi Farmaceutici S.p.A.
InventorBruno Pietro Imbimbo
Life of this patent
Estimating the term…
Abstract
The present invention relates to a process for production of nerve growth factor (NGF) and muteins thereof, in particular muteins of human NGF. The process of the present invention yields nerve growth factor (NGF) and muteins thereof, e.g. from recombinant sources, at high purity. Aspects related to the process of the present invention, such as muteins obtainable thereby, are also described. The respective muteins may be characterized e.g. by improved detectability and/or reduced nociceptive activity, compared to wildtype human NGF.
Claims16
A process for production of a mutein of nerve growth factor (NGF), wherein the mutein is characterized by more than 90% sequence identity with wild type human NGF (SEQ ID NO:
- 2),
- under the proviso that the mutein is characterized by at least one mutation, preferably amino acid substitution, at any of positions 95-101 of SEQ ID NO:
- 2,
- comprising the following steps:
- (a) obtaining a precursor of NGF or of the mutein thereof,
- (d) purification,
- wherein the purification comprises purification on a mixed mode stationary phase.
Dependencies are inferred from the claim text.